Biogen Inc. (BIIB)

Biogen Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	1,372	1,293	1,632	1,162	2,962	1,728
Depreciation & Amortization	801.1	779.9	673.2	494.8	518.4	487.7
Stock-Based Compensation	293.8	290.8	291.2	264.2	254.1	238.6
Other Adjustments	836.35	898.6	434.1	275.4	-1,460	1,332
Change in Receivables	222.4	42.1	194.2	56.7	-222.4	326
Changes in Inventories	-10.5	-64.7	-273.8	-130.9	-320.2	-462.4
Changes in Accrued Expenses	228.4	171.1	24.6	-201.6	-113.4	-95.4
Changes in Income Taxes Payable	-1,009	-958.1	78.5	-299	-142.3	230.8
Changes in Other Operating Activities	-283.5	-248	-178.7	-73.9	-92	-144.5
Operating Cash Flow	2,591	2,205	2,876	1,547	1,384	3,640
Operating Cash Flow Growth	0.36%	-23.33%	85.85%	11.77%	-61.97%	-13.95%
Capital Expenditures	-167.9	-153.8	-153.7	-277	-240.3	-258.1
Sale of Property, Plant & Equipment	-	-	-	-	582.6	93.5
Purchases of Intangible Assets	-56.6	-81.6	-206.1	-34.4	-2.9	-36.8
Proceeds from Sale of Intangible Assets	-	-	88.6	-	-	-
Purchases of Investments	-1,916	-1,258	-	-5,141	-3,449	-3,809
Proceeds from Sale of Investments	682.4	79.7	551.5	8,289	4,661	3,405
Payments for Business Acquisitions	-	-	-1,075	-6,926	-	-
Proceeds from Business Divestments	-	-	406.8	788.1	990.3	28.1
Other Investing Activities	7.9	-7.1	83.9	-11.3	24.4	-5.1
Investing Cash Flow	-1,533	-1,371	-799.2	-4,101	1,577	-563.7
Long-Term Debt Issued	866.4	1,733	-	997.2	-	-
Long-Term Debt Repaid	-875	-1,750	-650	-809.9	-1,002	-170
Net Long-Term Debt Issued (Repaid)	-8.6	-16.9	-650	187.3	-1,002	-170
Repurchase of Common Stock	-	-	-	-	-750	-1,800
Net Common Stock Issued (Repurchased)	-	-	-	-	-750	-1,800
Other Financing Activities	-164.5	-285	-33.5	-38	4.9	-116.2
Financing Cash Flow	-322.7	-301.9	-683.5	149.3	-1,747	-2,086
Effect of Exchange Rate Changes on Cash and Cash Equivalents	49.6	101.9	-67.7	35.1	-55.7	-59.8
Net Cash Flow	734.8	531.6	1,393	-2,405	1,214	990
Free Cash Flow	2,423	2,051	2,722	1,270	1,144	3,382
Free Cash Flow Growth	18.14%	-24.65%	114.28%	11.03%	-66.17%	-11.12%
FCF Margin	24.38%	20.73%	28.13%	12.91%	11.24%	30.79%
Free Cash Flow Per Share	16.46	13.94	18.66	8.72	7.84	22.61
Levered Free Cash Flow	287.3	802.4	1,152	860.8	1,570	1,316
Unlevered Free Cash Flow	1,148	1,073	2,097	956.48	2,480	2,513

Updated Apr 29, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q